Lv4
680 积分 2021-07-07 加入
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
FGFR2 Inhibition in Cholangiocarcinoma
1个月前
已完结
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
2个月前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
5个月前
已完结
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
5个月前
已完结
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer
5个月前
已完结
Targeting the Androgen Signaling Axis in Prostate Cancer
6个月前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
6个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
6个月前
已完结
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening
6个月前
已完结
皖公网安备34019202002308
